It was over before it began. After months of campaigning and badgering, billionaire investor Carl Icahn's slate of three directors challenging company nominees at Biogen Idec Inc. came up on the short end of a shareholder vote yesterday, and it didn't appear to be a close contest. ...
Anytime
